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The most recent revision of the World Health Organization (WHO) Classification of Tumours of Endocrine Organs introduced a
new variant of follicular thyroid carcinoma (FTC). It is characterized by a “glomeruloid” architectural pattern of growth. We
present a case of follicular tumor with glomeruloid features, with Alcian Blue positive mucinous stromal degeneration in foci of
questionable capsular microinvasion. At our knowledge, this the second case of glomeruloid follicular tumor in the literature
and the first case in which Alcian Blue staining was used to investigate capsular invasion. Moreover, RAS mutation further
supports that this is a variant of follicular tumor with uncertain malignant potential.
1. Introduction
The latest revision of theWorld Health Organization Classifica-
tion of Tumours of Endocrine Organs introduced a new variant
of follicular thyroid carcinoma (FTC) which is characterized by
a “glomeruloid” architectural pattern of growth. The term glo-
meruloid refers to an architectural model that mimics the renal
glomerulus, where the follicles contain round or oval epithelial
tufts growing within them [1]. This pattern has been previously
reported in some tumors, such as prostate adenocarcinoma,
breast carcinoma, mesothelioma, and vascular tumors [2, 3].
To date, only one case of glomeruloid FTC has been reported
in medical literature upon thyroid carcinomas [4].
Given the rarity of this neoplasia and difficulty of the
diagnosis, we report a new case of follicular tumor with glo-
meruloid features, in which the diagnosis of malignancy
was made more difficult by very focal capsular invasion.
However, the presence of mucinous stromal degeneration,
better highlighted by Alcian Blue staining, was useful to
detect it. To our knowledge, this is the second case of follicu-
lar thyroid carcinoma with glomeruloid features reported in
the literature and the first thyroid neoplasia with focal capsu-
lar invasion highlighted by Alcian Blue mucinous stromal
degeneration.
2. Case Presentation
A 40-year-old woman with history of Hashimoto thyroiditis
came to our hospital after an endocrinologist discovered a
palpable mass in the neck, on the left. The patient had no com-
pressive symptoms. The TSH level was normal at 1.12mIU/L.
Physical examination revealed an enlarged thyroid with a
30mm thyroid nodule with smooth edges. Thyroid sonogra-
phy showed an oval hypoechoic nodule in the left lobe of the
thyroid, surrounded by a thin, regular hyperechoic border,
measuring 32mm on its maximum diameter; the rest of the
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gland was slightly enlarged. FNA biopsy was performed. The
cytologic diagnosis was “follicular hyperplastic nodule” (Tir
2 SIAPEC-IAP 2014; Cat. II Bethesda 2008). Despite the cyto-
logical diagnosis, because of the progressive enlargement of
the nodule, a total thyroidectomy was performed.
2.1. Pathologic Findings. Grossly, the nodule was located in the
upper and middle third of the left lobe of the thyroid gland. It
measured 2:5 × 2 × 1:4 cm and appeared solid, encapsulated,
well-defined, and orange-greyish with a central hemorrhagic
area. The surgical specimen was fixed in neutral, buffered
10% formalin, and paraffin-embedded sections were stained
with hematoxylin and eosin and with Alcian Blue staining.
The immunohistochemical staining was carried out with the
BenchMark XT automated slide staining system (Ventana
Medical Systems, Tucson, AZ) according to the manufacturer’s
instructions, by using the following antibodies: TTF1, galectin-
3 (Gal-3), CK19, HBME-1, 34betaE12, and p53. Ki67.
As control, we retrieved from the archives of our institu-
tion fifteen cases of minimally invasive follicular carcinoma
consecutively observed in the last five years and fifteen cases
of follicular adenoma consecutively observed in the last two
years. We stained them with Alcian Blue staining.
Genomic DNA was extracted from 10μm paraffin-
embedded tumor sections. Slides were microscopically exam-
ined, and tumor areas were marked and carefully dissected
under microscopic observation. Dissected material was deparaf-
finized in xylene, washed in ethanol, and rehydrated. DNA
extractionwas performed using theQIAampTissueKit (Qiagen,
Hilden, Germany) according to the manufacturer’s protocol.
The histologic examination of the nodule showed a par-
tially encapsulated lesion with a microfollicular pattern of
growth. The follicles were often empty of colloid and lined
by cuboidal cells, without nuclear crowding and pseudostra-
tification. The presence of epithelial tufts growing within the
follicles, sometimes with a fibrovascular core, thus mimick-
ing the appearance of renal glomerulus, was occasionally
detected (Figures 1(a) and 1(b)).
Nuclei were small, round, and oval, with evenly distrib-




Figure 1: Neoplasia with microfollicular pattern of growth. The follicles are lined by cuboidal cells, lacking nuclear crowding and overlapping.
The arrows mark rare epithelial tufts growing within the follicles, with a fibrovascular core, mimicking the appearance of renal glomerulus (a, b)
and foci of capsular microinvasion (c, d, e) with stromal mucinous material (arrows) staining positively with Alcian Blue staining (f). H-E
staining: (a) =200x, (b) =400x, (c) =100x, (d) =200x, (e) =200x, and (f) =Alcian Blue staining, 200x.
2 Case Reports in Pathology
Nuclear features of papillary carcinoma (i.e., grooves, opti-
cally clear nuclei, or intranuclear cytoplasmic inclusions)
were not detected.
The capsule was thin, and after careful searching, a few foci
of questionable capsular microinvasion were found. Interest-
ingly, mucinous stromal material was evidenced at the periph-
ery of the lesion, in foci of microinvasion (Figures 1(c)–(e))
and at the interface between the tumor and the surrounding
parenchyma, where the capsule was absent (Figures 2(a) and
2(b)). Mucinous stromal material stained positively with
Alcian Blue staining (Figures 1(f) and 2(c)). It was absent
where the capsule was intact (Figure 2(d)) and in the central
areas of the lesion (Figure 1). The immunohistochemical assay
showed positive immunostaining for TTF1 and negative
immunostaining for HBME-1, Gal-3, 34betaE12, CK19, and
p53. Ki67 stained positively in 5% of nuclei. Alcian Blue posi-
tivematerial was not seen either in the foci of microinvasion of
the follicular tumor or near the capsule of follicular adenomas
used as control. Cytogenetic analysis showed a mutation in
exon 2 of N-RAS. The mutation in codon 61 consisted of a
CAA to CGA change that leads to a substitution of glutamine
by an arginine (p.Q61R), detected by a real-time, allele-specific
amplification essentially as described by Castro et al. [5].
3. Discussion
Follicular thyroid neoplasia with glomeruloid features is very
rare and since the first report, [4] no other cases have been
reported in literature except one case of follicular glomeru-
loid adenoma [6].
It is important to be aware of the existence of this neopla-
sia because the glomeruloid bodies could architecturally sim-
ulate the papillae of papillary carcinoma, from whom they
differ due to the lack of typical nuclear features. On the other
hand, because of the bland nuclear features, glomeruloid
bodies may be underestimated, mainly when they are scanty.
Therefore, some cases of glomeruloid carcinoma could be
underdiagnosed.
In our case, according to previous reports, the absence of
true papillae, of papillary nuclear changes, and the negative
immunostaining for HBME-1, Galectine 3, and CK19 sug-
gests the diagnosis of follicular neoplasia, in keeping with
cytogenetic analysis, showing N-RAS mutation [7]. In
contrast with the first case reported in the literature [4], some
differences were evidenced: in our case, the follicles were
made of bland cuboidal cells with no overlapping, unlike tall
and sometimes overlapping columnar cells described by
Cameselle-Teijeiro et al. [4]; the tumor showed only minimal
capsular invasion and stained negatively for 34betaE12,
CK19, p53, and HBME-1. The bland cytological features,
the absence of evident capsular invasion, and the immuno-
histochemical pattern made the diagnosis of malignancy
even more difficult. We would emphasize the presence of
Alcian blue positive stromal mucinous material near the foci
of questionable capsular microinvasion. Where the capsule
was absent, stromal mucinous degeneration was present at
the interface between the tumor and the surrounding paren-
chyma. No extracellular mucin deposition was found in the
central areas of the proliferation, unlike the extensive,
randommucin deposition reported in some follicular adeno-
mas [8]. So, this feature might evidence the advancing front
of the neoplasia. We want to emphasize the Alcian Blue
staining usefulness to highlight these foci of capsular micro-
invasion. Noteworthy, Alcian blue positive stromal mucinous
(a) (b)
(c) (d)
Figure 2: Stromal mucinous material (a, b) positive for Alcian Blue staining (c) at the interface between the tumor and the surrounding
parenchyma, in areas in which the capsule was absent (arrows). Stromal mucinous material was absent where the capsule was intact (d).
(a, b) H-E staining, 200x. (c, d) Alcian blue staining, 200x.
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degeneration was absent where the capsule was intact. None
of the FTC used as controls showed mucinous Alcian Blue
positive material in the foci of invasion, and neither it has
been reported in previous literature. We could hypothesize
that some enzymes secreted by the tumor, such as some
metalloproteases, could induce stromal degradation, thus
facilitating the invasion [9–11]. This hypothesis needs to be
further investigated on a larger number of cases, even to
confirm if this is a typical feature of “glomeruloid FTC.”
In keeping with the abovedescribed features, we diag-
nosed this case as “follicular tumor of uncertain malignant
potential (FT-UMP) with glomeruloid features.”
The prognosis of the patient was excellent after four years
follow-up, as expected for this diagnosis, but a longer follow-
up is necessary.
This is the first case of follicular tumor of uncertain
malignant potential (FT-UMP) with glomeruloid features
showing mucinous Alcian Blue positive stromal degeneration
in the foci of questionable capsular microinvasion. The
evidence of RAS mutation has further supported the current
WHO classification in considering this tumor as a form of
follicular neoplasm.
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Informed consent was obtained from the patient cited in the
study.
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